| Size | Price | Stock | Qty |
|---|---|---|---|
| 100mg |
|
||
| 250mg |
|
||
| 500mg | |||
| Other Sizes |
| ln Vitro |
Ectoine (0–5% (w/v); 0–24 hours; human RBCs) shields cells against SDS treatment-induced damage [1].
|
|---|---|
| References | |
| Additional Infomation |
Ectogenin is a carboxymidine heterocyclic compound formed by the condensation of (2S)-2,4-diaminobutyric acid and acetic acid. It is an osmotic regulator. Ectogenin belongs to the carboxymidine class of compounds, specifically a 1,4,5,6-tetrahydropyrimidine compound, and is also a monocarboxylic acid. It is the conjugate acid of ectogenin acid and also the tautomer of the zwitterion of ectogenin. Ectogenin is a metabolite found or produced in Escherichia coli (strains K12 and MG1655). It has also been reported in Streptomyces, marine methylphages, and other organisms with relevant data.
|
| Molecular Formula |
C6H10N2O2
|
|---|---|
| Molecular Weight |
142.1558
|
| Exact Mass |
142.074
|
| CAS # |
96702-03-3
|
| PubChem CID |
126041
|
| Appearance |
White to off-white solid powder
|
| Density |
1.4±0.1 g/cm3
|
| Boiling Point |
381.5±35.0 °C at 760 mmHg
|
| Melting Point |
~280°
|
| Flash Point |
184.5±25.9 °C
|
| Vapour Pressure |
0.0±1.9 mmHg at 25°C
|
| Index of Refraction |
1.597
|
| LogP |
0.27
|
| Hydrogen Bond Donor Count |
2
|
| Hydrogen Bond Acceptor Count |
3
|
| Rotatable Bond Count |
1
|
| Heavy Atom Count |
10
|
| Complexity |
177
|
| Defined Atom Stereocenter Count |
1
|
| SMILES |
C([C@@H]1CCN=C(C)N1)(=O)O
|
| InChi Key |
WQXNXVUDBPYKBA-YFKPBYRVSA-N
|
| InChi Code |
InChI=1S/C6H10N2O2/c1-4-7-3-2-5(8-4)6(9)10/h5H,2-3H2,1H3,(H,7,8)(H,9,10)/t5-/m0/s1
|
| Chemical Name |
(6S)-2-methyl-1,4,5,6-tetrahydropyrimidine-6-carboxylic acid
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
H2O : ~250 mg/mL (~1758.58 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: 100 mg/mL (703.43 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.
(Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 7.0343 mL | 35.1716 mL | 70.3433 mL | |
| 5 mM | 1.4069 mL | 7.0343 mL | 14.0687 mL | |
| 10 mM | 0.7034 mL | 3.5172 mL | 7.0343 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
